A study of nursing home residents found the monoclonal antibody treatment bamlanivimab cut the risk of COVID-19 by up to 80%, maker Eli Lilly announced.
Author: Karen Weintraub, USA TODAY
Moderna needs at least 3,000 adolescent volunteers for its COVID-19 vaccine trial. They’re struggling to find them.
More than 2 million minors were diagnosed with COVID-19 in 2020, and many more probably contracted the disease but were never diagnosed.
Millions of Americans with intellectual disabilities, at ‘particularly high risk’ for COVID-19, are still waiting for vaccinations
The vaccine priority level for people who live in group homes varies by state – even though they are more likely to be exposed to and die from COVID.
New coronavirus variants aren’t cause for alarm yet but mutations could make COVID harder to fight, experts say
The two authorized COVID-19 vaccines and others under development are expected to continue to be effective against the new strains of the coronavirus.
COVID-19 vaccine doses have been delivered but are sitting on pharmacy shelves. Longer delays could prolong the pandemic
If the pace of COVID-19 vaccination doesn’t pick up soon, the pandemic will continue to dominate life in America longer than officials have predicted.
US gets more help in raging battle against COVID-19 as FDA authorizes Moderna vaccine, the second allowed for emergency use
Moderna’s COVID vaccine, the second cleared for use in the U.S., will be shipped this weekend, with first doses expected to be given Monday.
FDA advisory committee to consider second COVID-19 vaccine, this one from Moderna, during all-day meeting
An FDA advisory panel is expected Thursday to recommend authorization of the COVID-19 vaccine developed by Moderna. It could be in states by Monday.
FDA advisory committee to consider second COVID-19 vaccine, this one from Moderna, during all-day meeting
An FDA advisory panel is expected Thursday to recommend authorization of the COVID-19 vaccine developed by Moderna. It could be in states by Monday.
German scientist Özlem Türeci was focused on cancer at BioNTech, then came COVID-19. It was her ‘duty’ to help develop a vaccine.
When Özlem Türeci, co-founder of BioNTech, first heard about the novel coronavirus, she knew her company would have to work on a vaccine to fight it.
‘A historic event for humanity’: US reaches turning point in fight against COVID-19 as FDA authorizes Pfizer vaccine
The FDA authorization clears the way for Americans to begin receiving Pfizer’s vaccine. First in line: Health care workers and nursing home residents.